NO995722L - Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer - Google Patents

Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Info

Publication number
NO995722L
NO995722L NO995722A NO995722A NO995722L NO 995722 L NO995722 L NO 995722L NO 995722 A NO995722 A NO 995722A NO 995722 A NO995722 A NO 995722A NO 995722 L NO995722 L NO 995722L
Authority
NO
Norway
Prior art keywords
treatment
autoimmune diseases
derivatives useful
triptolide derivatives
new
Prior art date
Application number
NO995722A
Other languages
English (en)
Other versions
NO995722D0 (no
Inventor
Michel Jean Jung
Mahinda Wickramaratne
Michael Hepperle
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO995722D0 publication Critical patent/NO995722D0/no
Publication of NO995722L publication Critical patent/NO995722L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995722A 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer NO995722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86248997A 1997-05-23 1997-05-23
PCT/US1998/008562 WO1998052933A1 (en) 1997-05-23 1998-04-27 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Publications (2)

Publication Number Publication Date
NO995722D0 NO995722D0 (no) 1999-11-22
NO995722L true NO995722L (no) 2000-01-21

Family

ID=25338618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995722A NO995722L (no) 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Country Status (17)

Country Link
EP (1) EP0983256B1 (no)
JP (1) JP2002500647A (no)
KR (1) KR20010012820A (no)
AR (1) AR012737A1 (no)
AT (1) ATE261434T1 (no)
AU (1) AU741209B2 (no)
BR (1) BR9809673A (no)
CA (1) CA2288327A1 (no)
DE (1) DE69822297T2 (no)
ES (1) ES2213279T3 (no)
HU (1) HUP0003244A3 (no)
IL (1) IL133089A0 (no)
NO (1) NO995722L (no)
NZ (1) NZ500699A (no)
TW (1) TW462966B (no)
WO (1) WO1998052933A1 (no)
ZA (1) ZA984177B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1390358A4 (en) * 2001-03-15 2004-06-16 Pharmagenesis Inc AMINO ACID DERIVATIVES OF TRIPTOLIDE COMPOUNDS AS IMMUNOMODULATORS AND ANTICROPHES
EP2468277A1 (en) 2002-05-31 2012-06-27 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
WO2005062913A2 (en) 2003-12-24 2005-07-14 Pharmagenesis, Inc. Triplide 5,6-derivatives as immunomodulators and anticancer agents
EP1722806A4 (en) 2004-02-09 2009-09-16 Pharmagenesis Inc METHOD OF ISOLATING TRIPTOLIDE COMPOUNDS FROM TRIPTERYGIUM WILFORDII
WO2005084365A2 (en) 2004-03-02 2005-09-15 Pharmagenesis, Inc. Triptolide lactone ring derivatives as immunomodulators and anticancer agents
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2006044496A2 (en) 2004-10-13 2006-04-27 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
DK2414542T3 (da) 2009-03-30 2017-11-27 Tel Hashomer Medical Res Infrastructure & Services Ltd Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
US20140086839A1 (en) 2011-03-17 2014-03-27 Tel Hashomer Medical Research Infrastructure And Services Ltd. Quinolone analogs for treating autoimmune diseases
ES2754207T3 (es) 2013-11-28 2020-04-16 Tel Hashomer Medical Res Infrastructure & Services Ltd Inhibidores de la ARN polimerasa I y usos de los mismos
CN113768939A (zh) * 2021-09-30 2021-12-10 深圳艾克斯恩生物科技有限公司 雷公藤二醇在制备预防和/或治疗nlrp3炎症小体介导的炎症性疾病药物中的应用
KR102875701B1 (ko) * 2022-12-28 2025-10-23 구주제약주식회사 신규 트립톨라이드 유도체 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026265A1 (en) * 1993-05-06 1994-11-24 Pharmagenesis, Inc. 16-hydroxytriptolide composition and method for immunotherapy
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
IL133089A0 (en) 2001-03-19
ATE261434T1 (de) 2004-03-15
HUP0003244A2 (en) 2001-03-28
BR9809673A (pt) 2000-07-11
HUP0003244A3 (en) 2001-09-28
AR012737A1 (es) 2000-11-08
TW462966B (en) 2001-11-11
ZA984177B (en) 1998-11-23
NZ500699A (en) 2001-08-31
DE69822297T2 (de) 2004-07-29
WO1998052933A1 (en) 1998-11-26
EP0983256A1 (en) 2000-03-08
AU741209B2 (en) 2001-11-22
AU7363498A (en) 1998-12-11
KR20010012820A (ko) 2001-02-26
JP2002500647A (ja) 2002-01-08
CA2288327A1 (en) 1998-11-26
EP0983256B1 (en) 2004-03-10
ES2213279T3 (es) 2004-08-16
HK1025954A1 (en) 2000-12-01
NO995722D0 (no) 1999-11-22
DE69822297D1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
NO995113D0 (no) Substituerte benzopyranderivater for behandling av inflammasjon
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO994256D0 (no) SmÕ molekyler som er anvendelige ved behandling av inflamasjonssykdom
NO995095L (no) Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer
FI962141A0 (fi) Rytmihäiriöitä vastustavat bentsodiatsepiinit
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
NO995723D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO973178D0 (no) Indol-derivater anvendelige ved behandling av osteporose
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO995722D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO306402B1 (no) 3-arylalkenyl-1,2,4-oksadiazolderivater og deres anvendelse, samt mellomprodukter for oppnaaelse av derivatene
NO986053L (no) Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis
NO930436L (no) Fremgangsmåte ved fremstilling av baderom
NO985325D0 (no) Anvendelse av substituert azaspiran ved behandling av astma
NO984190D0 (no) Fremgangsmåte for behandling av insomnia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application